IL-1, IL-6, TNF-α, and transforming growth factor beta (TGF-β) are pathogenically involved in AD neuroinflammatory process, which entails insulin axis failure and, consequently, cerebral glucose hypometabolism. The gene discussed is IL6; the disease is Alzheimer disease.